Author:
Cossu Vanessa,Bauckneht Matteo,Bruno Silvia,Orengo Anna Maria,Emionite Laura,Balza Enrica,Castellani Patrizia,Piccioli Patrizia,Miceli Alberto,Raffa Stefano,Borra Anna,Donegani Maria Isabella,Carlone Sebastiano,Morbelli Silvia,Ravera Silvia,Sambuceti Gianmario,Marini Cecilia
Reference46 articles.
1. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in national cancer institute trials;Shankar;J. Nucl. Med.,2006
2. Positron emission tomography (PET) in oncology;Gallamini;Cancers (Basel),2014
3. 18F-FDG PET/CT for staging and restaging of breast cancer;Groheux;J. Nucl. Med.,2016
4. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization;Jadvar;J. Nucl. Med.,2009
5. PET: the merging of biology and imaging into molecular imaging;Phelps;J. Nucl. Med.,2000